Archives: Resources
-
OLC Tolerability in CKD TiP
-
NKF24 OLC BE Study
-
NKF24 – OLC Dietitian Survey
-
UNI-494 Phase 1 Trial in Progress – CRRT 2024
-
UNI-494 AKI_IR Preclinical Study – CRRT 2024
-
RPS: Novel phosphate binder oxylanthanum carbonate effectively reduced serum and urine phosphorus concentrations in animal models
-
AJN: High Phosphate-Binding Capacity of Oxylanthanum Carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders
-
Oxylanthanum Carbonate (OLC) Sevelamer In-Vivo Phosphate Reduction Study
-
Oxylanthanum Carbonate (OLC) Phosphate Binders Daily Medication Volume Poster
-
UNI-494 DOG 28-Day Oral Toxicity Study